Rethinking clinical trials – how Tessa Jowell’s intervention could benefit people with cancer

Baroness Tessa Jowell has helped to raise awareness of the need for patients to access the latest drugs and treatments more quickly on the NHS. The ICR’s Rose Wu looks at why increasing flexibility around clinical trials could bring benefit to patients.
Institute of Cancer Research